AB154 drug page Clinical trials

Trials with AB154

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
1Recruiting
1Countries
917Planned patients

Showing 1–1 of 1

AB122 Platform Study
Recruiting Phase 1 917 patients NCT04999761

This is a phase 1, non-randomized open-label, multicenter platform study designed to evaluate the tolerability and safety of AB122 in patients with malignancies specified in each cohort.

Japan Jun 2021 – Jun 2027 Interventional

Where the recruiting trials are